Global and Japan Hemophilia A Drug Market Insights, Forecast to 2027

Global and Japan Hemophilia A Drug Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hemophilia A Drug Product Introduction
1.2 Market by Type
1.2.1 Global Hemophilia A Drug Market Size Growth Rate by Type
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Market by Application
1.3.1 Global Hemophilia A Drug Market Size Growth Rate by Application
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemophilia A Drug Market Size, Estimates and Forecasts
2.1.1 Global Hemophilia A Drug Revenue 2016-2027
2.1.2 Global Hemophilia A Drug Sales 2016-2027
2.2 Global Hemophilia A Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hemophilia A Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Hemophilia A Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hemophilia A Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hemophilia A Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hemophilia A Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Hemophilia A Drug Revenue Forecast by Region (2022-2027)
3 Global Hemophilia A Drug Competitor Landscape by Players
3.1 Global Top Hemophilia A Drug Manufacturers by Sales
3.1.1 Global Hemophilia A Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Hemophilia A Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hemophilia A Drug Manufacturers by Revenue
3.2.1 Key Hemophilia A Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hemophilia A Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Hemophilia A Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hemophilia A Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hemophilia A Drug Revenue in 2020
3.2.6 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemophilia A Drug Price by Manufacturers
3.4 Global Hemophilia A Drug Manufacturing Base Distribution, Product Types
3.4.1 Hemophilia A Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemophilia A Drug Product Type
3.4.3 Date of International Manufacturers Enter into Hemophilia A Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hemophilia A Drug Market Size by Type (2016-2021)
4.1.1 Global Hemophilia A Drug Sales by Type (2016-2021)
4.1.2 Global Hemophilia A Drug Revenue by Type (2016-2021)
4.1.3 Hemophilia A Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hemophilia A Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Hemophilia A Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Hemophilia A Drug Revenue Forecast by Type (2022-2027)
4.2.3 Hemophilia A Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hemophilia A Drug Market Size by Application (2016-2021)
5.1.1 Global Hemophilia A Drug Sales by Application (2016-2021)
5.1.2 Global Hemophilia A Drug Revenue by Application (2016-2021)
5.1.3 Hemophilia A Drug Price by Application (2016-2021)
5.2 Hemophilia A Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Hemophilia A Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Hemophilia A Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemophilia A Drug Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Hemophilia A Drug Market Size YoY Growth 2016-2027
6.1.1 Japan Hemophilia A Drug Sales YoY Growth 2016-2027
6.1.2 Japan Hemophilia A Drug Revenue YoY Growth 2016-2027
6.1.3 Japan Hemophilia A Drug Market Share in Global Market 2016-2027
6.2 Japan Hemophilia A Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Hemophilia A Drug Players by Sales (2016-2021)
6.2.2 Japan Top Hemophilia A Drug Players by Revenue (2016-2021)
6.3 Japan Hemophilia A Drug Historic Market Review by Type (2016-2021)
6.3.1 Japan Hemophilia A Drug Sales Market Share by Type (2016-2021)
6.3.2 Japan Hemophilia A Drug Revenue Market Share by Type (2016-2021)
6.3.3 Japan Hemophilia A Drug Price by Type (2016-2021)
6.4 Japan Hemophilia A Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Hemophilia A Drug Sales Forecast by Type (2022-2027)
6.4.2 Japan Hemophilia A Drug Revenue Forecast by Type (2022-2027)
6.4.3 Japan Hemophilia A Drug Price Forecast by Type (2022-2027)
6.5 Japan Hemophilia A Drug Historic Market Review by Application (2016-2021)
6.5.1 Japan Hemophilia A Drug Sales Market Share by Application (2016-2021)
6.5.2 Japan Hemophilia A Drug Revenue Market Share by Application (2016-2021)
6.5.3 Japan Hemophilia A Drug Price by Application (2016-2021)
6.6 Japan Hemophilia A Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Hemophilia A Drug Sales Forecast by Application (2022-2027)
6.6.2 Japan Hemophilia A Drug Revenue Forecast by Application (2022-2027)
6.6.3 Japan Hemophilia A Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hemophilia A Drug Market Size YoY Growth 2016-2027
7.2 North America Hemophilia A Drug Market Facts & Figures by Country
7.2.1 North America Hemophilia A Drug Sales by Country (2016-2021)
7.2.2 North America Hemophilia A Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hemophilia A Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hemophilia A Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Hemophilia A Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Hemophilia A Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Hemophilia A Drug Market Size YoY Growth 2016-2027
9.2 Europe Hemophilia A Drug Market Facts & Figures by Country
9.2.1 Europe Hemophilia A Drug Sales by Country (2016-2021)
9.2.2 Europe Hemophilia A Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hemophilia A Drug Market Size YoY Growth 2016-2027
10.2 Latin America Hemophilia A Drug Market Facts & Figures by Country
10.2.1 Latin America Hemophilia A Drug Sales by Country (2016-2021)
10.2.2 Latin America Hemophilia A Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hemophilia A Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hemophilia A Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemophilia A Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hemophilia A Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Description and Business Overview
12.1.3 Bayer AG Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer AG Hemophilia A Drug Products Offered
12.1.5 Bayer AG Recent Development
12.2 BioMarin Pharmaceutical Inc
12.2.1 BioMarin Pharmaceutical Inc Corporation Information
12.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
12.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Products Offered
12.2.5 BioMarin Pharmaceutical Inc Recent Development
12.3 Bioverativ Inc
12.3.1 Bioverativ Inc Corporation Information
12.3.2 Bioverativ Inc Description and Business Overview
12.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bioverativ Inc Hemophilia A Drug Products Offered
12.3.5 Bioverativ Inc Recent Development
12.4 Catalyst Biosciences Inc
12.4.1 Catalyst Biosciences Inc Corporation Information
12.4.2 Catalyst Biosciences Inc Description and Business Overview
12.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Catalyst Biosciences Inc Hemophilia A Drug Products Offered
12.4.5 Catalyst Biosciences Inc Recent Development
12.5 Chugai Pharmaceutical Co Ltd
12.5.1 Chugai Pharmaceutical Co Ltd Corporation Information
12.5.2 Chugai Pharmaceutical Co Ltd Description and Business Overview
12.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Products Offered
12.5.5 Chugai Pharmaceutical Co Ltd Recent Development
12.6 CSL Ltd
12.6.1 CSL Ltd Corporation Information
12.6.2 CSL Ltd Description and Business Overview
12.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CSL Ltd Hemophilia A Drug Products Offered
12.6.5 CSL Ltd Recent Development
12.7 DBV Technologies SA
12.7.1 DBV Technologies SA Corporation Information
12.7.2 DBV Technologies SA Description and Business Overview
12.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 DBV Technologies SA Hemophilia A Drug Products Offered
12.7.5 DBV Technologies SA Recent Development
12.8 Dimension Therapeutics Inc
12.8.1 Dimension Therapeutics Inc Corporation Information
12.8.2 Dimension Therapeutics Inc Description and Business Overview
12.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dimension Therapeutics Inc Hemophilia A Drug Products Offered
12.8.5 Dimension Therapeutics Inc Recent Development
12.9 EpiVax Inc
12.9.1 EpiVax Inc Corporation Information
12.9.2 EpiVax Inc Description and Business Overview
12.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 EpiVax Inc Hemophilia A Drug Products Offered
12.9.5 EpiVax Inc Recent Development
12.10 Expression Therapeutics LLC
12.10.1 Expression Therapeutics LLC Corporation Information
12.10.2 Expression Therapeutics LLC Description and Business Overview
12.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Expression Therapeutics LLC Hemophilia A Drug Products Offered
12.10.5 Expression Therapeutics LLC Recent Development
12.11 Bayer AG
12.11.1 Bayer AG Corporation Information
12.11.2 Bayer AG Description and Business Overview
12.11.3 Bayer AG Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer AG Hemophilia A Drug Products Offered
12.11.5 Bayer AG Recent Development
12.12 Idogen AB
12.12.1 Idogen AB Corporation Information
12.12.2 Idogen AB Description and Business Overview
12.12.3 Idogen AB Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Idogen AB Products Offered
12.12.5 Idogen AB Recent Development
12.13 Immusoft Corp
12.13.1 Immusoft Corp Corporation Information
12.13.2 Immusoft Corp Description and Business Overview
12.13.3 Immusoft Corp Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Immusoft Corp Products Offered
12.13.5 Immusoft Corp Recent Development
12.14 LFB SA
12.14.1 LFB SA Corporation Information
12.14.2 LFB SA Description and Business Overview
12.14.3 LFB SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 LFB SA Products Offered
12.14.5 LFB SA Recent Development
12.15 mAbxience SA
12.15.1 mAbxience SA Corporation Information
12.15.2 mAbxience SA Description and Business Overview
12.15.3 mAbxience SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 mAbxience SA Products Offered
12.15.5 mAbxience SA Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hemophilia A Drug Industry Trends
13.2 Hemophilia A Drug Market Drivers
13.3 Hemophilia A Drug Market Challenges
13.4 Hemophilia A Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemophilia A Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Hemophilia A Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ATXF-8117
Table 3. Major Manufacturers of BAY-1093884
Table 4. Major Manufacturers of BIVV-001
Table 5. Major Manufacturers of BS-027125
Table 6. Major Manufacturers of Concizumab
Table 7. Major Manufacturers of CSL-689
Table 8. Major Manufacturers of Others
Table 9. Global Hemophilia A Drug Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 10. Global Hemophilia A Drug Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Hemophilia A Drug Sales by Regions (2016-2021) & (K Pcs)
Table 12. Global Hemophilia A Drug Sales Market Share by Regions (2016-2021)
Table 13. Global Hemophilia A Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Hemophilia A Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 15. Global Hemophilia A Drug Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Hemophilia A Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Hemophilia A Drug Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Hemophilia A Drug Sales by Manufacturers (2016-2021) (K Pcs)
Table 19. Global Hemophilia A Drug Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Hemophilia A Drug Manufacturers by Revenue (US$ Million) in 2020
Table 21. Hemophilia A Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Hemophilia A Drug Revenue Share by Manufacturers (2016-2021)
Table 23. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A Drug as of 2020)
Table 25. Key Manufacturers Hemophilia A Drug Price (2016-2021) (USD/Pcs)
Table 26. Hemophilia A Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Hemophilia A Drug Product Type
Table 28. Date of International Manufacturers Enter into Hemophilia A Drug Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Hemophilia A Drug Sales by Type (2016-2021) (K Pcs)
Table 31. Global Hemophilia A Drug Sales Share by Type (2016-2021)
Table 32. Global Hemophilia A Drug Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Hemophilia A Drug Revenue Share by Type (2016-2021)
Table 34. Hemophilia A Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 35. Global Hemophilia A Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 36. Global Hemophilia A Drug Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Hemophilia A Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Hemophilia A Drug Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Hemophilia A Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 40. Global Hemophilia A Drug Sales by Application (2016-2021) (K Pcs)
Table 41. Global Hemophilia A Drug Sales Share by Application (2016-2021)
Table 42. Global Hemophilia A Drug Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Hemophilia A Drug Revenue Share by Application (2016-2021)
Table 44. Hemophilia A Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 45. Global Hemophilia A Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 46. Global Hemophilia A Drug Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Hemophilia A Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Hemophilia A Drug Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Hemophilia A Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 50. Japan Hemophilia A Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 51. Japan Hemophilia A Drug Sales Share by Company (2016-2021)
Table 52. Japan Hemophilia A Drug Revenue (US$ Million) by Company (2016-2021)
Table 53. Japan Hemophilia A Drug Revenue Share by Company (2016-2021)
Table 54. Japan Hemophilia A Drug Sales (K Pcs) by Type (2016-2021)
Table 55. Japan Hemophilia A Drug Sales Share by Type (2016-2021)
Table 56. Japan Hemophilia A Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. Japan Hemophilia A Drug Price (USD/Pcs) by Type (2016-2021)
Table 58. Japan Hemophilia A Drug Sales (K Pcs) by Type (2022-2027)
Table 59. Japan Hemophilia A Drug Sales Share by Type (2022-2027)
Table 60. Japan Hemophilia A Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. Japan Hemophilia A Drug Revenue Share by Type (2022-2027)
Table 62. Japan Hemophilia A Drug Price (USD/Pcs) by Type (2022-2027)
Table 63. Japan Hemophilia A Drug Sales (K Pcs) by Application (2016-2021)
Table 64. Japan Hemophilia A Drug Sales Share by Application (2016-2021)
Table 65. Japan Hemophilia A Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. Japan Hemophilia A Drug Price (USD/Pcs) by Application (2016-2021)
Table 67. Japan Hemophilia A Drug Sales (K Pcs) by Application (2022-2027)
Table 68. Japan Hemophilia A Drug Sales Share by Application (2022-2027)
Table 69. Japan Hemophilia A Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. Japan Hemophilia A Drug Revenue Share by Application (2022-2027)
Table 71. Japan Hemophilia A Drug Price (USD/Pcs) by Application (2022-2027)
Table 72. North America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 73. North America Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 74. North America Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs)
Table 77. Asia Pacific Hemophilia A Drug Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Hemophilia A Drug Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Hemophilia A Drug Revenue Market Share by Region (2016-2021)
Table 80. Europe Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 81. Europe Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 82. Europe Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 84. Latin America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 85. Latin America Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs)
Table 89. Middle East and Africa Hemophilia A Drug Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Hemophilia A Drug Revenue Market Share by Country (2016-2021)
Table 92. Bayer AG Corporation Information
Table 93. Bayer AG Description and Business Overview
Table 94. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. Bayer AG Hemophilia A Drug Product
Table 96. Bayer AG Recent Development
Table 97. BioMarin Pharmaceutical Inc Corporation Information
Table 98. BioMarin Pharmaceutical Inc Description and Business Overview
Table 99. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. BioMarin Pharmaceutical Inc Product
Table 101. BioMarin Pharmaceutical Inc Recent Development
Table 102. Bioverativ Inc Corporation Information
Table 103. Bioverativ Inc Description and Business Overview
Table 104. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Bioverativ Inc Product
Table 106. Bioverativ Inc Recent Development
Table 107. Catalyst Biosciences Inc Corporation Information
Table 108. Catalyst Biosciences Inc Description and Business Overview
Table 109. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Catalyst Biosciences Inc Product
Table 111. Catalyst Biosciences Inc Recent Development
Table 112. Chugai Pharmaceutical Co Ltd Corporation Information
Table 113. Chugai Pharmaceutical Co Ltd Description and Business Overview
Table 114. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Chugai Pharmaceutical Co Ltd Product
Table 116. Chugai Pharmaceutical Co Ltd Recent Development
Table 117. CSL Ltd Corporation Information
Table 118. CSL Ltd Description and Business Overview
Table 119. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. CSL Ltd Product
Table 121. CSL Ltd Recent Development
Table 122. DBV Technologies SA Corporation Information
Table 123. DBV Technologies SA Description and Business Overview
Table 124. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. DBV Technologies SA Product
Table 126. DBV Technologies SA Recent Development
Table 127. Dimension Therapeutics Inc Corporation Information
Table 128. Dimension Therapeutics Inc Description and Business Overview
Table 129. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. Dimension Therapeutics Inc Product
Table 131. Dimension Therapeutics Inc Recent Development
Table 132. EpiVax Inc Corporation Information
Table 133. EpiVax Inc Description and Business Overview
Table 134. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. EpiVax Inc Product
Table 136. EpiVax Inc Recent Development
Table 137. Expression Therapeutics LLC Corporation Information
Table 138. Expression Therapeutics LLC Description and Business Overview
Table 139. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 140. Expression Therapeutics LLC Product
Table 141. Expression Therapeutics LLC Recent Development
Table 142. Green Cross Corp Corporation Information
Table 143. Green Cross Corp Description and Business Overview
Table 144. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 145. Green Cross Corp Product
Table 146. Green Cross Corp Recent Development
Table 147. Idogen AB Corporation Information
Table 148. Idogen AB Description and Business Overview
Table 149. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 150. Idogen AB Product
Table 151. Idogen AB Recent Development
Table 152. Immusoft Corp Corporation Information
Table 153. Immusoft Corp Description and Business Overview
Table 154. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 155. Immusoft Corp Product
Table 156. Immusoft Corp Recent Development
Table 157. LFB SA Corporation Information
Table 158. LFB SA Description and Business Overview
Table 159. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 160. LFB SA Product
Table 161. LFB SA Recent Development
Table 162. mAbxience SA Corporation Information
Table 163. mAbxience SA Description and Business Overview
Table 164. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 165. mAbxience SA Product
Table 166. mAbxience SA Recent Development
Table 167. Hemophilia A Drug Market Trends
Table 168. Hemophilia A Drug Market Drivers
Table 169. Hemophilia A Drug Market Challenges
Table 170. Hemophilia A Drug Market Restraints
Table 171. Hemophilia A Drug Customers List
Table 172. Hemophilia A Drug Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia A Drug Product Picture
Figure 2. Global Hemophilia A Drug Sales Market Share by Type in 2020 & 2027
Figure 3. ATXF-8117 Product Picture
Figure 4. BAY-1093884 Product Picture
Figure 5. BIVV-001 Product Picture
Figure 6. BS-027125 Product Picture
Figure 7. Concizumab Product Picture
Figure 8. CSL-689 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hemophilia A Drug Sales Market Share by Application in 2020 & 2027
Figure 11. Clinic
Figure 12. Hospital
Figure 13. ASCs
Figure 14. Hemophilia A Drug Report Years Considered
Figure 15. Global Hemophilia A Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Hemophilia A Drug Market Size 2016-2027 (US$ Million)
Figure 17. Global Hemophilia A Drug Sales 2016-2027 (K Pcs)
Figure 18. Global Hemophilia A Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Hemophilia A Drug Sales Market Share by Region (2016-2021)
Figure 20. Global Hemophilia A Drug Sales Market Share by Region in 2020
Figure 21. Global Hemophilia A Drug Revenue Market Share by Region (2016-2021)
Figure 22. Global Hemophilia A Drug Revenue Market Share by Region in 2020
Figure 23. Global Hemophilia A Drug Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Hemophilia A Drug Revenue in 2020
Figure 25. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Hemophilia A Drug Sales Market Share by Type (2016-2021)
Figure 27. Global Hemophilia A Drug Sales Market Share by Type in 2020
Figure 28. Global Hemophilia A Drug Revenue Market Share by Type (2016-2021)
Figure 29. Global Hemophilia A Drug Revenue Market Share by Type in 2020
Figure 30. Global Hemophilia A Drug Sales Market Share by Application (2016-2021)
Figure 31. Global Hemophilia A Drug Sales Market Share by Application in 2020
Figure 32. Global Hemophilia A Drug Revenue Market Share by Application (2016-2021)
Figure 33. Global Hemophilia A Drug Revenue Market Share by Application in 2020
Figure 34. Japan Hemophilia A Drug Sales Growth Rate 2016-2027 (K Pcs)
Figure 35. Japan Hemophilia A Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. Japan Hemophilia A Drug Market Share in Global Market 2016-2027
Figure 37. Japan 5 and 10 Largest Hemophilia A Drug Players Market Share by Revenue in Hemophilia A Drug in 2020
Figure 38. Japan Hemophilia A Drug Revenue Share by Type (2016-2021)
Figure 39. Japan Hemophilia A Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 40. Japan Hemophilia A Drug Revenue Share by Application (2016-2021)
Figure 41. Japan Hemophilia A Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Hemophilia A Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 43. North America Hemophilia A Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Hemophilia A Drug Sales Market Share by Country in 2020
Figure 45. North America Hemophilia A Drug Revenue Market Share by Country in 2020
Figure 46. U.S. Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 47. U.S. Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 49. Canada Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Hemophilia A Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 51. Europe Hemophilia A Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Hemophilia A Drug Sales Market Share by Country in 2020
Figure 53. Europe Hemophilia A Drug Revenue Market Share by Country in 2020
Figure 54. Germany Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 55. Germany Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 57. France Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 59. U.K. Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 61. Italy Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 63. Russia Hemophilia A Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Hemophilia A Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 65. Asia Pacific Hemophilia A Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Hemophilia A Drug Sales Market Share by Region in 2020
Figure 67. Asia Pacific Hemophilia A Drug Revenue Market Share by Region in 2020
Figure 68. China Hemophilia A Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 69. Chi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs